To study the medicinal effectiveness of SafÅ«f Hajar-al YahÅ«d in patients of HasÄ?h al-Kulya (Nephrolithiasis).
- Conditions
- Health Condition 1: N200- Calculus of kidneyHealth Condition 2: null- HasÄ?h al-Kulya (Nephrolithiasis)
- Registration Number
- CTRI/2015/10/006276
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Patients with HasÄ?h al-Kulya (nephrolithiasis) as diagnosed by X-Ray/Ultrasound KUB with calculi measuring between 3 to 6 mm with or without any of the following symptoms:
•Bawl al-Dam (Haematuria)
•Siqlâ?? al-Khasira (Heaviness in the Loin)
•Wajaâ?? al-Khasira (Pain in the Loin)
•History of Recurrent UTI
•History of Recurrence of Renal Stone
•Urine showing Calcium Crystaluria
•Patients having acute condition of nephrolithiasis
•Complicated cases of nephrolithiasis requiring surgical intervention
•Patients with hydronephrosis, acute symptoms of UTI or any other renal diseases
•Patients with serum creatinine > 2mg%
•Patients on long-term medications
•Patients with cardiac, pulmonary or hepatic diseases
•Pregnancy and lactation
•Alcohol or drug abuse/ History of alcohol or drug abuse within 6 months prior to baseline
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-nephrolithic potential of Safūf Hajar-al Yahūd by using osteopontin, oxidative stress markers (Glutathione, Malondialdehyde, Superoxide dismutase) and electrolytes (Sodium, Potassium, Calcium, Phosphorous, Magnesium, Chloride).Timepoint: 8 WEEKS
- Secondary Outcome Measures
Name Time Method This study will help us to observe the role of osteopontin, oxidative stress markers and electrolytes in HasÄ?h al-Kulya (Nephrolithiasis).Timepoint: 8 WEEKS